Cargando…
NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells
Combination therapies or multi-targeted drugs have been pointed out as an option to prevent the emergence of resistant clones, which could make long-term treatment more effective and translate into better clinical outcomes for cancer patients. The NT157 compound is a synthetic tyrphostin that leads...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556623/ https://www.ncbi.nlm.nih.gov/pubmed/36224313 http://dx.doi.org/10.1038/s41598-022-21419-6 |